Recommendations for probiotic use-2011 update.
暂无分享,去创建一个
Stefano Guandalini | Harry J Flint | Mary Ellen Sanders | H. Flint | L. Brandt | G. Macfarlane | Y. Ringel | K. Madsen | L. Dieleman | W. Walker | C. Kelly | S. Guandalini | M. Sanders | Martin H Floch | W Allan Walker | Karen Madsen | George T Macfarlane | Levinus A Dieleman | Yehuda Ringel | Ciaran P Kelly | Lawrence J Brandt | M. Floch
[1] P. Brigidi,et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.
[2] S. Gorbach,et al. Probiotics for Prevention of Antibiotic-associated Diarrhea , 2008, Journal of clinical gastroenterology.
[3] H. Mykkänen,et al. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. , 1997, Journal of pediatric gastroenterology and nutrition.
[4] B. Kirschner,et al. Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study , 2000, Journal of pediatric gastroenterology and nutrition.
[5] F. Shanahan,et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. , 2005, Gastroenterology.
[6] H A Malchow,et al. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? , 1997, Journal of clinical gastroenterology.
[7] J. Katz. Probiotics for the Prevention of Antibiotic-associated Diarrhea and Clostridium difficile Diarrhea , 2006, Journal of clinical gastroenterology.
[8] D. Mack. Probiotics for ulcerative colitis therapy: Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial. Lancet 1999;354:635–9. , 2000 .
[9] M. Camilleri,et al. Recommendations for probiotic use. , 2006, Journal of clinical gastroenterology.
[10] S. Guandalini. Probiotics for Children With Diarrhea: An Update , 2008, Journal of clinical gastroenterology.
[11] H. Suomalainen,et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. , 1995, Vaccine.
[12] P. Testoni,et al. Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease , 2000, Digestive Diseases and Sciences.
[13] M. Kamm,et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis , 2003, Gut.
[14] C. Kelly,et al. Probiotics in clostridium difficile Infection. , 2011, Journal of clinical gastroenterology.
[15] M. Sanders. Impact of Probiotics on Colonizing Microbiota of the Gut , 2011, Journal of clinical gastroenterology.
[16] A. Zinsmeister,et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[17] J. Minkkinen,et al. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. , 1988, Clinical radiology.
[18] B. Rembacken,et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial , 1999, The Lancet.
[19] P. Whorwell,et al. Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome , 2006, The American Journal of Gastroenterology.
[20] Chyong-hsin Hsu,et al. Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Preterm Infants: A Multicenter, Randomized, Controlled Trial , 2008, Pediatrics.
[21] C. Surawicz. Role of Probiotics in Antibiotic-associated Diarrhea, Clostridium difficile-associated Diarrhea, and Recurrent Clostridium difficile-associated Diarrhea , 2008, Journal of clinical gastroenterology.
[22] G. Macfarlane,et al. Fermentation in the Human Large Intestine: Its Physiologic Consequences and the Potential Contribution of Prebiotics , 2011, Journal of clinical gastroenterology.
[23] P. Brigidi,et al. High-Dose Probiotics for the Treatment of Active Pouchitis , 2007, Diseases of the colon and rectum.
[24] K. Madsen. Interactions Between Microbes and the Gut Epithelium , 2011, Journal of clinical gastroenterology.
[25] Y. Ringel,et al. The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome , 2011, Journal of clinical gastroenterology.
[26] Gregor Reid,et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. , 2006, Microbes and infection.
[27] E Hilton,et al. Ingestion of Yogurt Containing Lactobacillus acidophilus as Prophylaxis for Candidal Vaginitis , 1992, Annals of Internal Medicine.
[28] J. Bakken,et al. Treating Clostridium difficile infection with fecal microbiota transplantation. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] C. Bulpitt,et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial , 2007, BMJ : British Medical Journal.
[30] M. Stolte,et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.
[31] H. Flint. Obesity and the Gut Microbiota , 2011, Journal of clinical gastroenterology.
[32] G. Reid,et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. , 2006, Microbes and infection.
[33] S. Pergolizzi,et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. , 2002 .
[34] P. Lionetti,et al. VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Crossover Study , 2010, Journal of pediatric gastroenterology and nutrition.
[35] H. Szajewska,et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. , 1998, Journal of pediatric gastroenterology and nutrition.
[36] E. Quigley,et al. Recommendations for probiotic use--2008. , 2008, Journal of clinical gastroenterology.
[37] O. Chassany,et al. Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial , 2007, Alimentary pharmacology & therapeutics.
[38] H. Hricak,et al. Evidence-based medicine. , 1997, Singapore medical journal.
[39] S. Salminen,et al. Probiotics: Use in Allergic Disorders: A Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report , 2008, Journal of clinical gastroenterology.
[40] L. Dieleman,et al. Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2011 , 2011, Journal of clinical gastroenterology.
[41] B. Birkenfeld,et al. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome , 2001, European journal of gastroenterology & hepatology.
[42] P. Brigidi,et al. Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial , 2000, Gastroenterology.
[43] R. Baldassano,et al. Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis , 2009, The American Journal of Gastroenterology.
[44] R. Bibiloni,et al. VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis , 2005, The American Journal of Gastroenterology.
[45] W. Walker,et al. Probiotics in the Prevention of Necrotizing Enterocolitis , 2011, Journal of clinical gastroenterology.
[46] A. Zinsmeister,et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome , 2003, Alimentary pharmacology & therapeutics.
[47] L. Brandt,et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection , 2018, Canadian Medical Association Journal.
[48] H. Szajewska,et al. Meta‐analysis: Saccharomyces boulardii for treating acute diarrhoea in children , 2006, Alimentary pharmacology & therapeutics.